Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTandem Diabetes Care Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 12 | -$0.51 | -$0.37 | -$0.44 |
| Q2 2026 | 11 | -$0.37 | -$0.17 | -$0.29 |
| Q3 2026 | 7 | -$0.17 | -$0.15 | -$0.16 |
| Q4 2026 | 4 | $0.13 | $0.15 | $0.14 |
| Q1 2027 | 4 | -$0.19 | -$0.16 | -$0.18 |
| Q2 2027 | 5 | -$0.06 | -$0.05 | -$0.06 |
| Q3 2027 | 8 | $0.03 | $0.03 | $0.03 |
| Q4 2027 | 4 | $0.23 | $0.26 | $0.24 |
| Q1 2028 | 5 | $0.11 | $0.13 | $0.12 |
| Q2 2028 | 7 | $0.20 | $0.23 | $0.22 |
| Q3 2028 | 10 | $0.23 | $0.25 | $0.24 |
| Q4 2028 | 5 | $0.40 | $0.45 | $0.43 |
Tandem Diabetes Care Inc Earnings Date And Information
Tandem Diabetes Care Inc last posted its earnings results on Thursday, February 19th, 2026. The company reported $-0.01 earnings per share for the quarter, topping analysts' consensus estimates of $-0.05 by $0.04. The company had revenue of 290.38 M for the quarter and had revenue of 1.01 B for the year. Tandem Diabetes Care Inc has generated $-3 earnings per share over the last year ($-3.04 diluted earnings per share) and currently has a price-to-earnings ratio of -6.03. Tandem Diabetes Care Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Tandem Diabetes Care Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/19/2026 | Q4 2025 | -$0.05 | -$0.01 | 0.04 | $277.01 M | $290.38 M |
| 11/06/2025 | Q3 2025 | -$0.31 | -$0.31 | 0 | $235.76 M | $249.25 M |
| 08/06/2025 | Q2 2025 | -$0.40 | -$0.78 | -0.38 | $238.58 M | $240.68 M |
| 04/30/2025 | Q1 2025 | -$0.60 | -$1.97 | -1.37 | $220.32 M | $234.42 M |
| 02/26/2025 | Q4 2024 | -$0.25 | $0.01 | 0.26 | $250.58 M | $282.65 M |
| 11/06/2024 | Q3 2024 | -$0.43 | -$0.35 | 0.08 | $224.14 M | $363.29 M |
| 08/01/2024 | Q2 2024 | -$0.54 | -$0.47 | 0.07 | $205.63 M | $221.91 M |
| 05/02/2024 | Q1 2024 | -$0.80 | -$0.65 | 0.15 | $174.52 M | $191.67 M |
| 02/21/2024 | Q4 2023 | -$0.23 | -$0.46 | -0.23 | N/A | $196.80 M |
| 11/01/2023 | Q3 2023 | -$0.35 | -$0.51 | -0.16 | N/A | $185.62 M |
| 08/03/2023 | Q2 2023 | -$0.54 | -$0.55 | -0.01 | N/A | $195.92 M |
| 05/03/2023 | Q1 2023 | -$0.56 | -$1.92 | -1.36 | N/A | $169.38 M |
| 02/22/2023 | Q4 2022 | -$0.00 | -$0.25 | -0.25 | N/A | $220.50 M |
| 11/02/2022 | Q3 2022 | -$0.05 | -$0.76 | -0.71 | N/A | $204.55 M |
| 08/03/2022 | Q2 2022 | -$0.02 | -$0.23 | -0.21 | N/A | $200.26 M |
| 05/04/2022 | Q1 2022 | -$0.07 | -$0.23 | -0.16 | N/A | $175.91 M |
| 02/22/2022 | Q4 2021 | $0.21 | $0.17 | -0.04 | N/A | $210.00 M |
| 11/03/2021 | Q3 2021 | $0.06 | $0.09 | 0.03 | N/A | $179.63 M |
| 08/04/2021 | Q2 2021 | -$0.08 | $0.06 | 0.14 | N/A | $172.14 M |
| 05/05/2021 | Q1 2021 | -$0.15 | -$0.08 | 0.07 | N/A | $141.04 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tandem Diabetes Care Inc Earnings: FAQ's
In the previous quarter, Tandem Diabetes Care Inc (:TNDM) reported $-0.01 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.05 by $0.04.
The conference call for Tandem Diabetes Care Inc's latest earnings report can be listened to online.
The conference call transcript for Tandem Diabetes Care Inc's latest earnings report can be read online.
Tandem Diabetes Care Inc (:TNDM) has a recorded annual revenue of $1.01 B.
Tandem Diabetes Care Inc (:TNDM) has a recorded net income of $-204,710,000.Tandem Diabetes Care Inc has generated $-3.04 earnings per share over the last four quarters.
Tandem Diabetes Care Inc (:TNDM) has a price-to-earnings ratio of -6.03 and price/earnings-to-growth ratio is 0.07.